Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive ibuprofen for uncomplicated lower limb cellulitis
ACTRN12611000515998Phase 3Completed
- Sponsor
- Dr Josh Davis
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cellulitis and erysipelas comparing Ibuprofen plus usual antibiotic therapy with Placebo plus usual antibiotic therapy (2 arms). Primary endpoint: Proportion of patients with regression of inflammation. Started Jun 2011; status: completed.
02
Drugs
ibuprofen
03
Conditions
cellulitiserysipelas
Beyond the preview
Go deeper on ACTRN12611000515998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000515998.